血栓
医学
血小板
溶栓
溶栓药
血小板活化
血栓形成
体内
尿激酶
药物输送
药理学
内科学
化学
生物
生物技术
心肌梗塞
有机化学
作者
Songli Wang,Ruifeng Wang,Nana Meng,Linwei Lu,Jun Wang,Jianfen Zhou,Jiasheng Lu,Qianzhu Xu,Cao Xie,Changyou Zhan,Yao Li,Yang Yu,Weiyue Lu,Min Liu
标识
DOI:10.1016/j.apsb.2022.01.004
摘要
Thrombolytic agents have thus far yielded limited therapeutic benefits in the treatment of thrombotic disease due to their short half-life, low targeting ability, and association with serious adverse reactions, such as bleeding complications. Inspired by the natural roles of platelets during thrombus formation, we fabricated a platelet-based delivery system ([email protected]/PLTs) comprising urokinase (uPA) and arginine (Arg) for targeted thrombolysis and inhibition of re-embolism. The anchoring of uPA to the platelet surface by lipid insertion increased the thrombotic targeting and in vivo circulation duration of uPA without disturbing platelet functions. Nitric oxide (NO) generated by the loaded Arg inhibited platelet aggregation and activation at the damaged blood vessel, thereby inhibiting re-embolism. [email protected]/PLTs effectively accumulated at the thrombi in pulmonary embolism and carotid artery thrombosis model mice and exerted superior thrombolytic efficacy. In addition, the platelet delivery system showed excellent thrombus recurrence prevention ability in a mouse model of secondary carotid artery injury. The coagulation indicators in vivo showed that the platelet-based uPA and NO co-delivery system possessed a low hemorrhagic risk, providing a promising tool for rapid thrombolysis and efficient inhibition of posttreatment re-embolism.
科研通智能强力驱动
Strongly Powered by AbleSci AI